CIPLA & BMS may settle patent dispute over Entecavir in India
30th May, 2015 - 12:16 pm
Categories:
IPAB
IPAB Decisions
News & Updates
patent infringement
Patents
pharma
0 Comments
US based pharma major Bristol-Myers Squibb (BMS) and Indian pharma company Cipla Ltd. are heading towards an amicable settlement on a long-stretched patent dispute concerning BMS’ hepatitis B drug Entecavir, a leading anti-viral drug for Hepatitis B patients that brings in more than a billion dollars each year globally for BMS. Entecavir, being a pre-1995 … Continue reading CIPLA & BMS may settle patent dispute over Entecavir in India
Read more »Part 3 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted
This is third and last part of the three part series dedicated to the discussion on the comparison of the Patent Term Extension laws of Europe and the United States of America (USA). While part one of three, which discussed the comparison of terms used for the extension of patent term in Europe and the … Continue reading Part 3 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted
Read more »Part 2 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted
This is second part of the three part series dedicated to the discussion on the comparison of the Patent Term Extension laws of Europe and the United States of America (USA). While part one of three, which discussed the comparison of terms used for the extension of patent term in Europe and the USA, relevant … Continue reading Part 2 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted
Read more »Part 1 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted
Many people love comparing and contrasting and I am one of those (at least for study purposes). This time, I am comparing Patent Term Extension laws for Europe and the United States of America (USA). Though there are other provisions that may extend the life of patent such as patent term adjustment to compensate the … Continue reading Part 1 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted
Read more »Recent Patent Litigation Cases (2014-15): India
29th April, 2015 - 5:30 am
Categories:
India
IP Litigation
IP Practice in India
News & Updates
patent infringement
Patent Litigation
Patents
0 Comments
Patent Litigation in India has steadily increased over the last 2-3 years. Dramatic swift has been observed in the innovator’s perspective from the mere aspect of the invention to gaining patent protection for their respective invention. Patent owners have adopted an aggressive approach towards their patent protection and enforcing their proprietary rights as businesses, which … Continue reading Recent Patent Litigation Cases (2014-15): India
Read more »ROLE OF DOCUMENTATION IN PROTECTING TRADITIONAL KNOWLEDGE
Domestic and International laws prohibit patenting of traditional knowledge of any local community. However, the traditional knowledge, such as unique plants and their use is being usurped by unscrupulous players by patenting them in different countries. Only way to stall such moves is by providing prior art evidences proving that the knowledge was already available … Continue reading ROLE OF DOCUMENTATION IN PROTECTING TRADITIONAL KNOWLEDGE
Read more »Improving Regulatory Transparency for New Medical Therapies Act
A new act passed in the U.S. house of representative: What will it protect? Patent exclusivity, non-patent exclusivity, or both? Anything else also it deals with? The bill titled ‘A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to … Continue reading Improving Regulatory Transparency for New Medical Therapies Act
Read more »Supreme Court stayed the Delhi High Court order of injunction against Glenmark over the Generic drug “Sitagliptin”
2nd April, 2015 - 10:04 am
Categories:
India
IP Litigation
IP Practice in India
News & Updates
patent infringement
Patent Litigation
Patents
pharma
Pharma/Biotech Patent Litigations
0 Comments
Reportedly, Hon’ble Supreme Court of India on Special Leave Petition filed by Glenmark stayed the Delhi High Court order which passed injunction against Glenmark for the generic drug Sitagliptin till 28th April 2015. The Delhi high court on dated 20th March 2015 set aside an order of single judge bench of Delhi High Court which … Continue reading Supreme Court stayed the Delhi High Court order of injunction against Glenmark over the Generic drug “Sitagliptin”
Read more »E- Filing of Application for Registration of Geographical Indications in India
Controller General of Patents, Designs and Trademarks issued public notice dated 11 March 2015 launching electronic filing of application for registration of Geographical Indication (GI) in India. Now the application for registration of GI can be submitted online to the Registrar of GI through the official portal at www.ipindia.gov.in or www.ipindia.nic.in. The payment for the … Continue reading E- Filing of Application for Registration of Geographical Indications in India
Read more »Recent decision of Delhi High Court in the case of GILEAD PHARMASSET, LLC V. UNION OF INDIA & ANR
23rd February, 2015 - 7:46 am
Categories:
IP Practice in India
News & Updates
Patents
pharma
Section 3(D)
0 Comments
Recently, the Delhi high court on dated 30th January 2015 set aside an order of the Deputy Controller of Patents and Designs. The impugned order rejected a patent to US drug maker Gilead for its hepatitis C drug “Sovaldi” on dated 13th January 2015. Facts of the case: M/S GILEAD PHARMASSET, INC, USA, filed a … Continue reading Recent decision of Delhi High Court in the case of GILEAD PHARMASSET, LLC V. UNION OF INDIA & ANR
Read more »